MESO Mesoblast ADRs

Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. This is an ADR of a company whose stock trades outside of the U.S. as the symbol AT:MSB.

$9.26  -0.34 (-3.54%)
As of 03/02/2021 15:57:58 EST     IEX book   CBOE book